New defense tested for transplant patients at highest risk of dangerous virus
Disease control
Recruiting now
This study is testing whether giving antibody infusions (CytoGam®) after standard preventive antiviral medication ends can help prevent late CMV infection in high-risk organ transplant patients. It will enroll 80 adults who received a kidney, liver, or combined liver-kidney trans…
Phase: PHASE4 • Sponsor: Camille N. Kotton, MD • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC